Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q87615370)
Watch
English
GLP-1 receptor agonists: why is once weekly inferior to once daily?
scientific article published on 06 February 2014
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
title
GLP-1 receptor agonists: why is once weekly inferior to once daily?
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
author name string
Alan J Garber
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
publication date
6 February 2014
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
published in
The Lancet: Diabetes & Endocrinology
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
volume
2
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
issue
4
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
page(s)
266-267
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
cites work
Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970014-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970014-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970014-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970014-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970014-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measuring psychological insulin resistance: barriers to insulin use
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-8587%2814%2970014-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S2213-8587(14)70014-2
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
PubMed ID
24703036
1 reference
stated in
Europe PubMed Central
PubMed ID
24703036
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24703036%20AND%20SRC:MED&resulttype=core&format=json
retrieved
13 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
